Literature DB >> 10516372

Pathobiology of the role of iron in infection.

G Sunder-Plassmann1, S I Patruta, W H Hörl.   

Abstract

Beyond its role in hemoglobin synthesis, iron plays an important part in host defense mechanisms. Sequestration of iron is a mechanism to control bacterial proliferation and virulence. However, uremia results in several immunologic deficits, including impaired lymphocyte mitogenic response and granulocyte function abnormalities such as impaired phagocytosis, respiratory burst, and myeloperoxidase activity. At the other end of the spectrum, iron overload can impair immune function and stimulate bacterial growth and virulence. Overtreatment with iron increases the preexisting risk of infectious complications for uremic patients, as indicated by hyperferritinemia in hemodialysis patients who have impaired polymorphonuclear leukocyte (PMNL)-induced bacterial killing. These results suggest that maintaining iron status within normal range is important to control potential increased risk of infection in patients with end-stage renal disease (ESRD).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516372     DOI: 10.1053/AJKD034s00025

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Testing two (of several) intravenous iron dosing strategies in hemodialysis.

Authors:  Margaret K Yu; Glenn M Chertow
Journal:  Ann Transl Med       Date:  2019-07

3.  Infection with Mycobacterium avium differentially regulates the expression of iron transport protein mRNA in murine peritoneal macrophages.

Authors:  W Zhong; W P Lafuse; B S Zwilling
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 4.  Iron and infection in hemodialysis patients.

Authors:  Julie H Ishida; Kirsten L Johansen
Journal:  Semin Dial       Date:  2013-12-12       Impact factor: 3.455

5.  Intravenous iron exposure and mortality in patients on hemodialysis.

Authors:  Dana C Miskulin; Navdeep Tangri; Karen Bandeen-Roche; Jing Zhou; Aidan McDermott; Klemens B Meyer; Patti L Ephraim; Wieneke M Michels; Bernard G Jaar; Deidra C Crews; Julia J Scialla; Stephen M Sozio; Tariq Shafi; Albert W Wu; Courtney Cook; L Ebony Boulware
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

6.  Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection.

Authors:  Julie H Ishida; Ben J Marafino; Charles E McCulloch; Lorien S Dalrymple; R Adams Dudley; Barbara A Grimes; Kirsten L Johansen
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-28       Impact factor: 8.237

7.  Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study.

Authors:  Idan Goren; Adi Brom; Henit Yanai; Amir Dagan; Gad Segal; Ariel Israel
Journal:  United European Gastroenterol J       Date:  2019-09-05       Impact factor: 4.623

8.  Prevention of siderophore- mediated gut-derived sepsis due to P. aeruginosa can be achieved without iron provision by maintaining local phosphate abundance: role of pH.

Authors:  Kathleen Romanowski; Alexander Zaborin; Hoylan Fernandez; Valeriy Poroyko; Vesta Valuckaite; Svetlana Gerdes; Donald C Liu; Olga Y Zaborina; John C Alverdy
Journal:  BMC Microbiol       Date:  2011-09-26       Impact factor: 3.605

Review 9.  Interpretation of the Kidney Disease: Improving Global Outcomes guidelines for iron therapy: commentary and emerging evidence.

Authors:  Jeffrey S Berns
Journal:  Clin Kidney J       Date:  2017-11-28

Review 10.  Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease.

Authors:  Simon D Roger
Journal:  Clin Kidney J       Date:  2017-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.